2306193-99-5 (2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbutanoyl)- 4-hydroxy-N-(2-hydroxy-4-(4- methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide 98%

Kalam Sai Life Sciences Private Limited was founded in 2021 as a drug discovery, development, and manufacturing company. The company employs a staff of highly skilled and experienced scientists with competence in the major emphasis areas of a successful drug discovery, development, and manufacturing company. The company is dedicated to researching and manufacturing novel medications that improve patient outcomes and quality of life.

KSL’s significant skills in API synthesis, Custom Synthesis, Process Development, CRAMS, analytical, and manufacturing are among its primary competencies. The organization has cutting-edge facilities that enable it to offer high-quality services in these areas. KSL is committed to providing its customers with the finest available solutions and services, which it accomplishes through using cutting-edge technology, equipment, and procedures.

KSL’s capabilities are also expanding to incorporate high-quality formulations, with a focus on producing new and effective treatments that fulfill the needs of patients. KSL relies on bright and motivated teams committed to producing high-quality results to achieve this. Because the organizationrealizes the value of keeping talent and encouraging its people to innovate, it treats its staff with the utmost respect.